3,4-dihydro-2-chloromethyl naphthalene | 62620-52-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 英文名称: 3,4-dihydro-2-chloromethyl naphthalene
• 英文别名: 3-(chloromethyl)-1,2-dihydronaphthalene；3-chloromethyl-1,2-dihydro-naphthalene；3-Chlormethyl-1,2-dihydro-naphthalin
• CAS: 62620-52-4
• 化学式: C₁₁H₁₁Cl
• 分子量: 178.661
• InChiKey: CRXCUWXIIRDCNT-UHFFFAOYSA-N

物化性质

• 沸点：
  141-144 °C(Press: 13 Torr)
• 密度：
  1.1382 g/cm3

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  12
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.27
• 拓扑面积：
  0
• 氢给体数：
  0
• 氢受体数：
  0

反应信息

• 作为反应物：
  描述：

  3,4-dihydro-2-chloromethyl naphthalene 在 乌洛托品 、 溶剂黄146 作用下， 生成 3,4-二氢萘-2-甲醛
  参考文献：
  名称：

  Petru; Rehor, Collection of Czechoslovak Chemical Communications, 1958, vol. 23, p. 1157

  摘要：

  DOI：
• 作为产物：
  描述：

  1,2-dihydro-3-hydroxymethylnaphthalene 在 N-氯代丁二酰亚胺 、 二甲基硫 作用下， 以 二氯甲烷 为溶剂， 以54%的产率得到3,4-dihydro-2-chloromethyl naphthalene
  参考文献：
  名称：

  β-和γ-双取代烯烃：铜催化不对称烯丙基取代的底物

  摘要：

  铜催化的不对称烯丙基烷基化通过许多实例表明，它是用单β-和γ-取代的烯烃底物生成立体异构中心的有效手段。然而，关于更多取代的烯烃图案，例如β-二取代的烯丙基亲电试剂，几乎没有报道。在本文中，我们表明，使用容易获得的格氏试剂和低至3 mol％的铜/配体的简单程序可以促进高至近乎完美的对映选择性（高达> 99％ee），并且在很宽的范围内具有很好的γ选择性一组脂族或芳族β-二取代底物。

  DOI：

  10.1002/adsc.200800086

文献信息

• Pyrimidine-thioalkyl and alkylether compounds
  申请人：PHARMACIA & UPJOHN COMPANY

  公开号：EP1247804A1

  公开（公告）日：2002-10-09

  The subject invention relates to pyrimidine-thioalkyl and alkylether compounds of Formula I and pyrimidine-thioalkyl and alkylethers of Formula IA, namely the compounds of Formula I where R4 is selected from the group consisting of -H or -NR15R16 where R15 is -H and R16 is -H, C1-C6 alkyl, -NH2 or R15 and R16 taken together with the -N form 1-pyrrolidino, 1-morpholino or 1-piperidino; and R6 is selected from the group consisting of -H, or halo (preferably -Cl); with the overall provisio that R4 and R6 are not both -H; The compounds of Formula IA are useful in the treatment of individuals who are HIV positive.

  该发明涉及Formula I的嘧啶硫代烷基和烷基醚化合物，以及Formula IA的嘧啶硫代烷基和烷基醚化合物，即Formula I中R4选自-H或-NR15R16的基团，其中R15为-H，R16为-H，C1-C6烷基，-NH2或R15和R16一起与-N形成1-吡咯啉基、1-吗啉基或1-哌啶基；以及R6选自-H或卤素（优选-Cl）的基团，总体规定是R4和R6不能同时为-H；Formula IA的化合物在治疗HIV阳性个体中是有用的。
• 1,3,8-Triazaspiro(4.5)decan-4-one derivatives
  申请人：E. R. Squibb & Sons, Inc.

  公开号：US04051248A1

  公开（公告）日：1977-09-27

  Compounds having the structure ##STR1## and the pharmaceutically acceptable salts thereof, wherein R.sub.1 is hydrogen, halogen, hydroxy, alkanoyloxy, alkoxy, alkylthio, alkyl or trifluoromethyl; R.sub.2 is hydrogen, alkyl or alkenyl; R.sub.3 is hydrogen, halogen or alkyl; R.sub.4 is formyloxy or alkanoyloxy; m is 1 or 2; and n is 0, 1 or 2; have useful physiological activity.

  具有结构##STR1##及其药用可接受盐的化合物，其中R.sub.1为氢、卤素、羟基、烷酰氧基、烷氧基、烷基硫基、烷基或三氟甲基；R.sub.2为氢、烷基或烯基；R.sub.3为氢、卤素或烷基；R.sub.4为甲酰氧基或烷酰氧基；m为1或2；n为0、1或2；具有有用的生理活性。
• 1,2,3,4-Tetrahydro-2-((4-(phenyl)-1-piperazinyl)methyl)-1-naphthalenols
  申请人：E. R. Squibb & Sons, Inc.

  公开号：US04130646A1

  公开（公告）日：1978-12-19

  Compounds having the structure ##STR1## and pharmaceutically acceptible salts thereof, wherein R.sub.1 is hydrogen, halogen, hydroxy, alkanoyloxy, alkoxy, alkylthio, alkyl, trifluoromethyl or methylenedioxy; R.sub.2 is hydrogen, halogen, alkyl, alkoxy, alkylthio, or trifluoromethyl; R.sub.3 is formyl or alkanoyl; m is 1 or 2; and n is 0, 1 or 2, have useful sedative and muscle relaxant activity, and can be used as tranquilizers.

  具有结构##STR1##及其药用可接受盐的化合物，其中R.sub.1为氢、卤素、羟基、烷酰氧基、烷氧基、烷基硫基、烷基、三氟甲基或亚甲二氧基；R.sub.2为氢、卤素、烷基、烷氧基、烷基硫基或三氟甲基；R.sub.3为甲酰基或烷酰基；m为1或2；n为0、1或2，具有有用的镇静和肌肉松弛作用，并可用作镇定剂。
• 4,5,7,8-tetrahydro-6H-thiazolo[5,4-d]azepines, their preparation and
  申请人：Karl Thomae GmbH

  公开号：US05068325A1

  公开（公告）日：1991-11-26

  The present invention relates to new 4,5,7,8-tetrahydro-6H-thiazolo[5,4-d]azepines of general formula II ##STR1## wherein the substituents are defined herein below, which compounds have valuable pharmacological properties, namely selective effects on the dopaminergic system which are achieved by stimulating (predominantly D2) dopamine receptors.

  本发明涉及一种新的4,5,7,8-四氢-6H-噻唑并[5,4-d]氮杂环庚烷通式II ##STR1## 其中取代基在下文中定义，这些化合物具有有价值的药理作用，即通过刺激（主要是D2）多巴胺受体实现对多巴胺系统的选择性影响。
• Benzocondensed derivatives as rigid analogues of the μ-opioid agonist 3(8)-cinnamyl-8(3)-propionyl-3,8-diazabicyclo[3.2.1]octanes: synthesis, modeling, and affinity
  作者：G Cignarella、D Barlocco、P Vianello、S Villa、G.A Pinna、P Fadda、W Fratta、L Toma、S Gessi

  DOI：10.1016/s0014-827x(98)00084-6

  日期：1998.11

  A new series of rigid analogues (1a-g, 2a-g) of the previously reported analgesic 3-cinnamyl-8-propionyl-3,8-diazabicyclo[3.2.1]octane (I) and its reverted isomer 3-propionyl-8-cinnamyl (II) were synthesized, in which the cinnamyl substituent is incorporated in benzocondensed bicyclic systems. Binding assays for the affinity towards mu receptors indicated that, while in the reverted series 2 the beta-naphthylmethyl (2d) and the benzocycloheptenylmethyl derivative (2g) favorably compared with II, all compounds 1 displayed a mu-affinity lower than that of the parent I. Modeling studies suggest that the flexibility of the cinnamyl side chain plays an important role for activity. (C) 1998 Elsevier Science S.A. All rights reserved.